81 related articles for article (PubMed ID: 494629)
21. Fibrinogen/fibrin degradation products in the diagnosis of pulmonary embolism in critically ill patients.
Jareno AJ; de la Serna JL; Corral EE; Gallego J; Patino R
Crit Care Med; 1980 Nov; 8(11):646-50. PubMed ID: 7428389
[TBL] [Abstract][Full Text] [Related]
22. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Soroka VR
Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
[TBL] [Abstract][Full Text] [Related]
23. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
24. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
Astrug A; Shipkova P
Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
[TBL] [Abstract][Full Text] [Related]
25. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
[TBL] [Abstract][Full Text] [Related]
26. [Fibrinogen and fibrin degradation products (FDP) in serum of patients with acute myocardial infarct and with imminent infarct].
Kedra M; Kutarski A; Dmoxzyńska A
Pol Tyg Lek; 1975 Sep; 30(37):1517-21. PubMed ID: 1161615
[No Abstract] [Full Text] [Related]
27. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
28. [Role of D-dimer test in excluding pulmonary embolism in patients with suspected pulmonary embolism in an Emergency Department].
Zonzin P
Ital Heart J Suppl; 2001 Dec; 2(12):1357-9. PubMed ID: 11838359
[No Abstract] [Full Text] [Related]
29. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
Sato N; Takahashi H; Nikuni K; Seki Y; Wada K; Tatewaki W; Shibata A
Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324
[TBL] [Abstract][Full Text] [Related]
30. [Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
Perdigão C; Monteiro J; Nunes V; Varela MG; Geraldes MJ; Araújo A; Pais F; Ferreira D; Ribeiro C
Rev Port Cardiol; 1992 Nov; 11(11):951-9. PubMed ID: 1290642
[TBL] [Abstract][Full Text] [Related]
31. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
32. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
Lalos O; Frankendal B; Rudolphi O
Ann Chir Gynaecol; 1977; 66(3):131-134. PubMed ID: 327909
[TBL] [Abstract][Full Text] [Related]
33. [Study on the fibrin fibrinogen degradation products levels and it's significance in the phlegm of the patients with chronic cor pulmonale through monoclonal antibodies].
He GZ
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):154-6, 191. PubMed ID: 2249318
[TBL] [Abstract][Full Text] [Related]
34. [Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Matsuda T
Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):628-36. PubMed ID: 4677378
[No Abstract] [Full Text] [Related]
35. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
36. [Study on cases of D dimer values were dissociated from FDP-E].
Himizu M; Ishii K; Katagiri H; Saga K; Ono F; Yamamoto M; Todoroki T; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
[TBL] [Abstract][Full Text] [Related]
37. [Determination of fibrin-fibrinogen degradation products in the serum of newborn infants using a standardized hemagglutination inhibition test (the FDP kit)].
Weitzel KH; Eschenbach C
Monatsschr Kinderheilkd; 1984 Jan; 132(1):23-8. PubMed ID: 6700599
[TBL] [Abstract][Full Text] [Related]
38. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases].
Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV
Vasa; 1976; 5(4):332-7. PubMed ID: 1007541
[No Abstract] [Full Text] [Related]
39. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
Chi DS; Chen JP
Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
[TBL] [Abstract][Full Text] [Related]
40. [Study of fibrinogen degradation products in rheumatic diseases].
Murav'ev IuV
Ter Arkh; 1980; 52(6):84-7. PubMed ID: 7404395
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
